Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pilot Trial of Eculizumab Therapy to Reduce Preservation Injury in Human Macrosteatotic Liver Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03468140
Recruitment Status : Recruiting
First Posted : March 16, 2018
Last Update Posted : September 9, 2019
Sponsor:
Collaborators:
Ochsner Health System
Alexion Pharmaceuticals
Information provided by (Responsible Party):
Yale University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2019
Estimated Study Completion Date : December 31, 2020